Arcus Biosciences, Inc. (RCUS)
23.14
-1.42
(-5.78%)
USD |
NYSE |
Jan 15, 13:06
Arcus Biosciences SG&A Expense (TTM): 112.00M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Gilead Sciences, Inc. | 5.886B |
| Actinium Pharmaceuticals, Inc. | 15.79M |
| Madrigal Pharmaceuticals, Inc. | 715.08M |
| Karyopharm Therapeutics, Inc. | 109.63M |
| Janux Therapeutics, Inc. | 39.13M |